Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

The VITAL Trial: Phase II Trial of V osaroxin and I nfusional Cytarabine for Frontline T reatment of a cute Myeloid L eukemia

Stephen A Strickland, MD MSCI, Nikolai A. Podoltsev, MD PhD, Sanjay R Mohan, MD MSCI, Amer M. Zeidan, MBBS, MHS, Merrida A Childress, PhD, Gregory D Ayers, MS, Michael T Byrne, DO, Steven D. Gore, MD, Robert K. Stuart, MD, Michael R. Savona, MD

Blood (2019) 134 (Supplement_1): 180.

https://doi.org/10.1182/blood-2019-131520

Published: 2019

Journal Articles

Application of Autologous Artificial Tears in a Case of an 8-Year-Old Girl with Vernal Keratoconjunctivitis (Spring Catarrh)

Pawel Jozef Laguna, Jolanta Antoniewicz-Papis, Alina Szajkowska, Magdalena Letowska, Tomasz Szczepański, MD PhD, Michal Matysiak, Prof, MD PhD

Blood (2017) 130 (Supplement 1): 4931.

https://doi.org/10.1182/blood.V130.Suppl_1.4931.4931

Published: 2017

Journal Articles

Phase II Trial of Vosaroxin and Infusional Cytarabine for Frontline Treatment of Acute Myeloid Leukemia (VITAL) Patients Eligible for Intensive Chemotherapy: A Planned Interim Analysis

Stephen A. Strickland, MD MSCI, Nikolai A. Podoltsev, MD PhD, Sanjay R. Mohan, MD MSCI, Amer M. Zeidan, MD, Gregory D. Ayers, MS, Molly Olson, MS, Steven D. Gore, MD, Robert K. Stuart, MD, Michael R. Savona, MD

Blood (2017) 130 (Supplement 1): 2630.

https://doi.org/10.1182/blood.V130.Suppl_1.2630.2630

Published: 2017

Journal Articles

Pralatrexate: Phase 1/2 Study in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)

Yoshinobu Maeda, MD PhD, Kensei Tobinai, MD, PhD, Hirokazu Nagai, MD PhD, Takahiko Nakane, MD, PhD, Tatsu Shimoyama, MD, Tomonori Nakazato, Rika Sakai, Takayuki Ishikawa, MD, PhD, Koji Izutsu, MD PhD, Ryuzo Ueda, MD PhD

Blood (2016) 128 (22): 4157.

https://doi.org/10.1182/blood.V128.22.4157.4157

Published: 2016

Journal Articles

New Cooling Device for Oral Mucosa Better Tolerated and Equally Effective As Ice Cooling

Java Walladbegi, DDS, PhDStudent, Anncarin Svanberg, RN, PhD, Gunnar Birgegard, MD PhD, Mats Jontell, DDS, PhD Prof.

Blood (2016) 128 (22): 5806.

https://doi.org/10.1182/blood.V128.22.5806.5806

Published: 2016

Journal Articles

Equivalent Cyclophosphamide Efficacy Against Leukemia in Mice Treated with Topical Vasoconstrictors

Amanda Jo Graul-Conroy, MD / M.S., Emily J Hicks, Margo L. Hoover-Regan, MD, William E. Fahl, PhD

Blood (2015) 126 (23): 5455.

https://doi.org/10.1182/blood.V126.23.5455.5455

Published: 2015

Journal Articles

2-Hour Cryotherapy Effectively Reduces Severe Mucositis Associated with High-Dose Melphalan Followed By Stem Cell Rescue: Results from a Randomized Trial

Douglas W. Sborov, MD, Misty Lamprecht, CNS, Don Benson, MD PhD, Karen Tackett, RN, Yvonne A Efebera, MD, Rosko E Ashley, MD, Steven M. Devine, MD, Ming Poi, PharmD, PhD, Mitch A. Phelps, PhD, Craig C Hofmeister, MD MPH

Blood (2014) 124 (21): 3960.

https://doi.org/10.1182/blood.V124.21.3960.3960

Published: 2014

Journal Articles

Oral Cryotherapy For The Prevention Of Mucositis Following Myeloablative Conditioning and Hematopoietic Stem Cell Transplantation

Yin Lu, Xiaming Zhu, Wu Depei

Blood (2013) 122 (21): 5466.

https://doi.org/10.1182/blood.V122.21.5466.5466

Published: 2013

Journal Articles

Cryotherapy Reduces Mucositis in Multiple Myeloma Patients Receiving High-Dose Melphalan Conditioning Prior to Autologous Stem Cell Transplantation

Mabel Rodriguez, PharmD, Nelly G. Adel, PharmD, BCOP, BCPS, Sean Devlin, PhD, Sergio A Giralt, MD, Heather Landau, MD

Blood (2012) 120 (21): 4265.

https://doi.org/10.1182/blood.V120.21.4265.4265

Published: 2012

Journal Articles

Unexpected 5 Year Survival Benefit in Patients Given Oral Cryotherapy During Conditioning for Stem Cell Transplantation. A Prospective Randomized Study

Anncarin Svanberg, Kerstin Öhrn, Gunnar Birgegard, MD, PhD

Blood (2011) 118 (21): 4559.

https://doi.org/10.1182/blood.V118.21.4559.4559

Published: 2011

Journal Articles

High-Dose Melphalan and Autologous Stem Cell Transplantation In AL Amyloidosis and Monoclonal Immunoglobulin Deposition Disease Associated End-Stage Renal Disease Requiring Dialysis

Vaishali Sanchorawala, MD, Karen Quillen, MD, MPH, Kathleen T Finn, ANP, Nancy T Andrea, MD, J. Mark Sloan, MD, Laura Dember, MD, Adam Segal, MD, Gheorghe Doros, PhD, Martha Skinner, MD, David Seldin, MD

Blood (2010) 116 (21): 3553.

https://doi.org/10.1182/blood.V116.21.3553.3553

Published: 2010

Journal Articles

Multivariate Analysis of Factors Influencing Stomatitis in Allogeneic Hematopoietic Stem Cell Transplantation.

Yumiko Ohbayashi, Osamu Imataki, Hiroaki Ohnishi, Minoru Miyake, Akinori Iwasaki, Takaaki Ogawa, Akira Kitanaka, Yoshitsugu Kubota, Terukazu Tanaka, Toshihiko Ishida, Shunichiro Nagahata

Blood (2007) 110 (11): 4937.

https://doi.org/10.1182/blood.V110.11.4937.4937

Published: 2007

Journal Articles

Palifermin Treatment in Patients Receiving High Dose Melphalan or BEAM Prior to Autologous Peripheral Blood Stem-Cell Transplantation.

Anne Sonet, MD, G. Bries, MD, N. Meulemans, MD, A. Van Hoof, MD, E. Steel, MD, M. André, MD, A. Ferrant, MD, N. Straetmans, MD, P. Zachée, MD, V. Robin, MD, H. Demuynck, MD, L. Noens, MD, A. Bosly, MD, M. Delforge, MD, D. Bron, MD

Blood (2006) 108 (11): 5241.

https://doi.org/10.1182/blood.V108.11.5241.5241

Published: 2006

NARROW

The VITAL Trial: Phase II Trial of V osaroxin and I nfusional Cytarabine for Frontline T reatment of a cute Myeloid L eukemia

Application of Autologous Artificial Tears in a Case of an 8-Year-Old Girl with Vernal Keratoconjunctivitis (Spring Catarrh)

Phase II Trial of Vosaroxin and Infusional Cytarabine for Frontline Treatment of Acute Myeloid Leukemia (VITAL) Patients Eligible for Intensive Chemotherapy: A Planned Interim Analysis

Pralatrexate: Phase 1/2 Study in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)

New Cooling Device for Oral Mucosa Better Tolerated and Equally Effective As Ice Cooling

Equivalent Cyclophosphamide Efficacy Against Leukemia in Mice Treated with Topical Vasoconstrictors

2-Hour Cryotherapy Effectively Reduces Severe Mucositis Associated with High-Dose Melphalan Followed By Stem Cell Rescue: Results from a Randomized Trial

Oral Cryotherapy For The Prevention Of Mucositis Following Myeloablative Conditioning and Hematopoietic Stem Cell Transplantation

Cryotherapy Reduces Mucositis in Multiple Myeloma Patients Receiving High-Dose Melphalan Conditioning Prior to Autologous Stem Cell Transplantation

Unexpected 5 Year Survival Benefit in Patients Given Oral Cryotherapy During Conditioning for Stem Cell Transplantation. A Prospective Randomized Study

High-Dose Melphalan and Autologous Stem Cell Transplantation In AL Amyloidosis and Monoclonal Immunoglobulin Deposition Disease Associated End-Stage Renal Disease Requiring Dialysis

Multivariate Analysis of Factors Influencing Stomatitis in Allogeneic Hematopoietic Stem Cell Transplantation.

Palifermin Treatment in Patients Receiving High Dose Melphalan or BEAM Prior to Autologous Peripheral Blood Stem-Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only